Modern Advances in Melanoma Treatment: Immunotherapy & BRAF Inhibitors
Dr. Elena Rodriguez, MDApril 1, 20268 min read
How systemic treatments have transformed stage III and IV melanoma survival rates over the last decade.
The Era of Checkpoint Inhibitor Immunotherapy
Pembrolizumab and Nivolumab unleash the patient's immune system to attack metastasized melanoma cells with unprecedented long-term survival.
This article is educational and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified dermatologist or other licensed health provider with questions about a medical condition.
Looking for a specialist in this area? Browse Melanoma Diagnosis & Staging
